Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Demodex And Psoriasis"

23:54 EDT 16th April 2014 | BioPortfolio

Original Source: Demodex mites: Facts and controversies.

Because Demodex mites are ubiquitous, their potential as human pathogens has often been ignored. This contribution focuses on the growing body of evidence linking Demodex mites with various skin disorders. Histologically, spongiosis and lymphoid inflammation are regularly seen in follicles containing Demodex mites. In animals, they are well established as a cause of mange, and a human counterpart-demodectic alopecia-appears to exist. There is also a statistical association between Demodex mite density and r...

Matching Channels

Psoriasis and Scaling Diseases

C5a R Antagonists

The interaction of complement C5a and its receptor for the treatment of inflammatory diseases include rheumatoid arthritis, systemic lupus erythematosus, asthma, wet age-related macular degeneration...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Phosphodiesterase 4 PDE 4 Inhibitors

Phosphodiesterase 4 (PDE-4) inhibitors have attracted considerable interest as potential therapeutic agents for diseases including chronic obstructive pulmonary disease. PDE-4 inhibitors are known to...

Interleukin 17 IL 17R IL 17

The IL-17 family consists of six ligands, A-F. IL-17 was originally thought to signal via the classic receptor IL-17R, but IL17 stimulates a receptor complex that consists of the subunits IL-17RA and...

Matching News

Psoriasis registry: an interview with Dr. Andrew D. Robertson, Chief Scientific and Medical Officer, National Psoriasis Foundation

Psoriasis is the most common autoimmune disease in the US, affecting 2 to 3% of all Americans. What causes psoriasis in any one individual will stem from a mixture of their genetic background and thei...

NPF, CORRONA to create first psoriasis registry to improve treatments and patient outcomes

To advance understanding of psoriasis—the most common autoimmune disease in the country, affecting up to 7.5 million Americans—and help scientists and clinicians improve treatments and patient out...

Psoriasis researchers identify molecular changes responsible for skin discoloration

(Medical Xpress)—Itchy, painful rashes—such as those that occur with psoriasis—are uncomfortable, but at least they fade when the flare-up subsides. Mostly. Evidence often remains in the form of...

Gene identified that offers a new target for psoriasis treatment

Researchers at King's College London have identified a new gene (PIM1), which could be an effective target for innovative treatments and therapies for the human autoimmune disease, psoriasis.Psoriasis...

Janssen’s psoriasis drug Stelara set to generate $1.4 billion by 2015

Psoriasis drug Stelara (ustekinumab), from US health care giant Johnson & Johnson’s subsidiary Janssen Biotech, is set to become the leading brand among systemic treatments for psoriasis by 2017, ac...

CARD14 c.526G>C (p.Asp176His) Is a Significant Risk Factor for Generalized Pustular Psoriasis with Psoriasis Vulgaris in the Japanese Cohort

Dermatologists prescribe steroids for psoriasis management, despite guidelines that discourage use

A new study indicates that systemic corticosteroids are prescribed by dermatologists even though expert guidelines discourage their use for psoriasis treatment. Researchers found that systemic cortico...

THERAPEUTIC CLASS OVERVIEW : PSORIASIS – PLAQUE PSORIASIS & PSORIATIC ARTHRITIS : NOVEL ORAL DRUGS AND BIOLOGICS TO CHANGE FUTURE TREATMENT PARADIGM

Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded considerably and improved patients’ pain, function, and quality of life. Approved b...

Matching PubMed Articles

Human demodex mite: the versatile mite of dermatological importance.

Demodex mite is an obligate human ecto-parasite found in or near the pilo-sebaceous units. Demodex folliculorum and Demodex brevis are two species typically found on humans. Demodex infestation usuall...

Bariatric surgery and psoriasis.

Obesity is associated with psoriasis and poses a significant obstacle to psoriasis management. Bariatric surgery is an effective procedure for weight loss, and some reports suggest that it may improve...

The Prevalence of Demodex sp. in Patients Admitted to the Parasitology Laboratory of the Dursun Odabaş Medical Center in Yüzüncü Yıl University, Van.

Objective: The aim of the study was to determine the prevalence of Demodex sp. in patients referred fom the Dermatology Outpatient Clinic to the Parasitology Laboratory, Dursun Odabaş Medical Center...

Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil to Kill Demodex Mites.

To determine the active ingredient in tea tree oil (TTO) responsible for its reported killing effect on Demodex mites, the most common ectoparasite found in the human skin extending to the eye.

Hypercholesterolemia and Risk of Incident Psoriasis and Psoriatic Arthritis in US Women.

Psoriasis is a systemic inflammatory disorder associated with an increased risk of cardiovascular disease. Hypercholesterolemia is a major risk factor for cardiovascular disease, and patients with pso...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement